GLP-1

Spotting Vulnerable GLP-1 patients

Psychologist Kimberley Cairns proposes a cognitively informed GLP-1 approach for aesthetic practice Glucagon-like peptide-1 (GLP-1) receptor agonists have reshaped discussions around weight, identity and appearance. In UK aesthetic practice, clinicians are increasingly seeing patients whose bodies, and sometimes decision-making, are …

Read More »

Maintaining GLP-1 Weight Loss Through Body Devices

Dr Marwa Ali examines the role of body devices in GLP-1–associated weight loss The use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide and tirzepatide, has grown rapidly in medical weight management.¹ With patients achieving significant weight loss and …

Read More »

CPD: Treating Muscle Loss with Devices

Skeletal muscle is a dynamic, metabolically active organ essential for maintaining health throughout the lifespan. Beyond providing strength and locomotion, muscle regulates glucose metabolism, supports immune signalling and contributes to endocrine communication through the secretion of myokines.1 A decline in …

Read More »

Managing Post-Weight Loss Skin Changes

Dr Ahmed El Muntasar presents an overview of strategies for addressing post-weight loss skin changes Significant weight loss, whether achieved through lifestyle modification, bariatric surgery or pharmacological interventions such as glucagon-like peptide-1 (GLP-1) receptor agonists, is increasingly common in clinical …

Read More »

Special Feature: Treating Upper Arm Laxity Following Weight Loss

Three practitioners discuss the pathophysiology of skin laxity and evaluate treatment modalities aimed at optimising both aesthetic appearance and functional outcomes Weight loss can result from a variety of interventions. For example, lifestyle modifications including diet and exercise promote gradual, …

Read More »

Understanding How Fasting Helps Metabolic Stability

Dr Vix Manning and Dr Charlotte Woodward examine how medically supervised FMD protocols address post-GLP-1 metabolic instability The landscape of metabolic medicine has been revolutionised by GLP-1 and GIP receptor agonists, with remarkable success in achieving rapid weight loss and …

Read More »